Inhibrx Biosciences Inc Q4 2021 Earnings Report

Total Revenue
$2.86M
Previous year: $2.78M
+2.9%
EPS
-$0.55
Previous year: -$0.47
+17.0%

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc